# DEX vs SEVO in Congenital Heart Surgery

Study · id `cardio:ct-nct05369949` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05369949](<https://clinicaltrials.gov/study/NCT05369949>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05369949

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT05369949. Randomized; no masking; primary purpose treatment. Start 2023-01-05 (anticipated); primary completion 2025-12-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT05369949, source copy `cardio:ctgov-nct05369949-2022-09-23`, retrieved 2026-10-26)
- Planned start: 2023-01-05 (anticipated) (ClinicalTrials.gov record NCT05369949, source copy `cardio:ctgov-nct05369949-2022-09-23`, retrieved 2026-10-26)
- Primary completion: 2025-12-30 (anticipated) (ClinicalTrials.gov record NCT05369949, source copy `cardio:ctgov-nct05369949-2022-09-23`, retrieved 2026-10-26)
- Completion: 2026-06-30 (anticipated) (ClinicalTrials.gov record NCT05369949, source copy `cardio:ctgov-nct05369949-2022-09-23`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05369949-2022-09-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: DEX vs SEVO in Congenital Heart Surgery
- Acronym: DEXLOSNeuro
- Condition: Heart Defects, Congenital
- Intervention (Drug): DEX group
- Intervention (Other): Control group
- Lead sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry lists this organization as the lead sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain (`cardio:org-cliniques-universitaires-saint-luc-universite-catholique-de-a23a89`)

## Provenance

Content hash: 6872ac575a8ffaf506fad51c2876aaa7093d325c4a7d294c28d1ab69a0fa73dc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
